https://www.selleckchem.com/pr....oducts/atezolizumab.
The surface electromyography (sEMG) signal has been used for volitional control of robotic assistive devices. There are still challenges in improving system performance accuracy and signal processing to remove systematic noise. This study presents procedures and a pilot validation of the EMG-driven speed-control of exoskeleton and integrated treadmill with a goal to provide better interaction between a user and the system. The gait cycle duration (GCD) was extracted from sEMG signals using the autocorrelation algorithm and Bayesian